Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

49.67
-1.1600-2.28%
Post-market: 49.670.00000.00%18:34 EDT
Volume:2.30M
Turnover:114.82M
Market Cap:121.02B
PE:18.22
High:50.30
Open:49.46
Low:49.32
Close:50.83
Loading ...

Sanofi's Mixed Itepekimab Results Make Amlitelimab Trial More Important -- Market Talk

Dow Jones
·
02 Jun

Berenberg Trims Price Target on Sanofi to EUR118 From EUR120, Keeps Buy Rating

MT Newswires Live
·
02 Jun

Sanofi resumed with an Equal Weight at Morgan Stanley

TIPRANKS
·
02 Jun

Blueprint Medicines Soars 26% as Sanofi to Buy the US Biopharma Group in $9.1 Bln Deal

Bloomberg
·
02 Jun

Berenberg Bank Sticks to Their Buy Rating for Sanofi (SNY)

TIPRANKS
·
02 Jun

Post-Bell | S&P 500 Posts Biggest Monthly Pct Gain Since November 2023; Nvidia and Tesla Drop 3%; Gap Sinks 20%

Tiger Newspress
·
31 May

Regeneron dashes Wall Street's hopes as COPD treatment trial suffers a failure

Dow Jones
·
31 May

European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading

MT Newswires Live
·
30 May

Sanofi Down Over 5%, On Track for Largest Percent Decrease Since October 2023 -- Data Talk

Dow Jones
·
30 May

Sector Update: Health Care Stocks Fall Pre-Bell Friday

MT Newswires Live
·
30 May

Exchange-Traded Funds Mixed, Equity Futures Lower Pre-Bell Friday Amid US Tariff Reinstatement Decision

MT Newswires Live
·
30 May

Sanofi, Regeneron Hit by Trial Disappointment -- Market Talk

Dow Jones
·
30 May

Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials

GlobeNewswire
·
30 May

Regeneron Pharmaceuticals' True Value Masked by Eylea Concerns, RBC Says

MT Newswires Live
·
27 May

Sanofi (SNY) Receives a Hold from TD Cowen

TIPRANKS
·
27 May

The New Covid-19 Jab Policy Wasn't Up for Debate at the FDA's Vaccine Meeting. Major Questions Remain. -- Barrons.com

Dow Jones
·
24 May

Sanofi Opens New Offices in New Jersey

MT Newswires Live
·
23 May

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live
·
23 May

Vigil Neuroscience downgraded to Hold from Buy at Jefferies

TIPRANKS
·
23 May

Sanofi to Acquire Vigil Neuroscience in $470 Million Deal to Boost Neurological Pipeline

Reuters
·
22 May